Proactive Investors - Run By Investors For Investors

MedaPhor slides as wider loss expected for 2018 despite revenue rise

The firm said it expected a pre-exceptionals EBITDA loss for 2018 of around £3mln, wider than the £1.7mln loss in 2017 and in spite of a predicted 27% increase in revenues
Ultrasound
MedaPhor develops ultrasound simulation and AI software

Ultrasound software firm MedaPhor Group PLC (LON:MED) saw its shares slide in early trading Monday after its forecast a wider loss for 2018 despite an increase in revenues.

In a trading update for the year to 31 December, the firm said it expected a pre-exceptionals EBITDA loss of around £3mln, wider than the £1.7mln loss in 2017 and in spite of a predicted 27% increase in revenues to between £5.3mln and £5.4mln.

The company said the loss included around £1.5mln of research and development (R&D) expenses attributable to an investment in the firm’s Clinical Artificial Intelligence Division which was established in October 2017 following the acquisition of Intelligent Ultrasound Limited.

MedaPhor added that it had received £4.86mln in December from a placing and open offer with a year-end cash balance of £5.5mln compared to £4.3mln at the end of 2017.

Shares were down 3.2% at 7.5p.

View full MED profile View Profile

MedaPhor Timeline

Newswire
August 27 2014

Related Articles

cancer scan
January 03 2019
The company, which owns a piece of software which predicts the effects of drugs on cancers, has recently extended a lucrative agreement with German firm Merck Serono while it has also signed a strategic collaboration with the Medicines Discovery Catapult
researcher
April 30 2019
We take a look at a company with a unique approach to drug development that may ultimately help big pharma replenish its pipeline
An illustration of Ozop's BLIF technique
March 30 2019
A key area of focus for the West Palm Beach, Florida, company is development of balloon lumbar interbody fusion (BLIF) technology

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use